Concepedia

Carolynn E. Ohlson

CE

Statistics

Publications

5

Citations

906

H-Index

5

Active since

2013

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Dana-Farber/Harvard Cancer Center

Brigham and Women's Hospital

Carolynn E. Ohlson is an author at Dana-Farber Cancer Institute specializing in oncology, cancer cell signaling, and signal transduction in cancer.

Publications per year

2013–2018

5

Publications

5

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

Liya Ding, Hye‐Jung Kim, Qiwei Wang et al. · Cell Reports · 2018 · 571 citations · Full text

, , +17

PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer

Jennifer M. Spangle, Koen M.A. Dreijerink, Anna C. Groner et al. · Cell Reports · 2016 · 119 citations · Full text

, , +17

PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α

Lauren M. Thorpe, Jennifer M. Spangle, Carolynn E. Ohlson et al. · Proceedings of the National Academy of Sciences · 2017 · 107 citations · Full text

, , +16

A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition

Hailing Cheng, Pixu Liu, Fan Zhang et al. · Cancer Research · 2013 · 60 citations · Full text

, , +17

PIK3CAH1047R- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling

Hailing Cheng, P Liu, Carolynn E. Ohlson et al. · Oncogene · 2015 · 49 citations · Full text

, , +16

1–5 of 5